U.S. Markets closed

PolarityTE, Inc. (PTE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6915+0.0433 (+6.68%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6482
Open0.6600
Bid0.6750 x 2200
Ask0.6830 x 3100
Day's Range0.6401 - 0.7160
52 Week Range0.5500 - 4.6000
Volume2,022,495
Avg. Volume1,009,209
Market Cap27.135M
Beta (5Y Monthly)1.71
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 12, 2016
1y Target EstN/A
  • Benzinga

    Recap: PolarityTE Q3 Earnings

    Shares of PolarityTE (NASDAQ:PTE) moved higher by 7.3% in pre-market trading after the company reported Q3 results.Quarterly Results Earnings per share increased 79.31% over the past year to ($0.18), which beat the estimate of ($0.21).Revenue of $3,337,000 higher by 139.21% from the same period last year, which beat the estimate of $2,970,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.PolarityTE hasn't issued any revenue guidance for the time being.Conference Call Details Date: Nov 09, 2020View more earnings on PTETime: 08:00 AMET Webcast URL: https://event.webcasts.com/starthere.jsp?ei=1392187&tp_key=366f166ce8Recent Stock Performance 52-week high: $4.60Company's 52-week low was at $0.78Price action over last quarter: down 32.24%Company Description PolarityTE Inc is a commercial-stage biotechnology and regenerative biomaterials company. Its focused on transforming the lives of patients by discovering, designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Its product includes SkinTE used for repair, reconstruction, replacement or regeneration of skin in patients who have or require treatment of acute and chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. It operates in two segments: the regenerative medicine business segment and the contract research segment.See more from Benzinga * Click here for options trades from Benzinga * 12 Healthcare Stocks Moving In Tuesday's Pre-Market Session * 12 Healthcare Stocks Moving In Monday's After-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Should You Buy PolarityTE, Inc. (PTE)?
    Insider Monkey

    Should You Buy PolarityTE, Inc. (PTE)?

    Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

  • Rising P/E: An Overlooked Trick to Pick 5 Winning Stocks
    Zacks

    Rising P/E: An Overlooked Trick to Pick 5 Winning Stocks

    Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.